Abstract: An acquisition control unit acquires spot urine nutritional component indexes of nutritional component indexes contained in one spot urine excreted by a human. The nutritional component indexes two or more selected from a sodium/potassium ratio indicating a ratio, a magnesium/creatinine ratio, an urea-nitrogen/creatinine ratio, and a sodium/creatinine ratio. The determination control unit compares the spot urine nutritional component index with a reference value preset for the spot urine nutritional component index for each of spot urine nutritional component indexes, and determines whether or not the spot urine nutritional component index is equal to or more than the reference value. The decision control unit decides a diet evaluation pattern indicating a balance of the diet of the human from the determination result for each of the determined spot urine nutritional component indexes. The output control unit outputs a diet evaluation comment improving the balance of the diet of the human.

Abstract: An acquisition control unit acquires spot urine nutritional component indexes of nutritional component indexes contained in one spot urine excreted by a human. The nutritional component indexes two or more selected from a sodium/potassium ratio indicating a ratio, a magnesium/creatinine ratio, an urea-nitrogen/creatinine ratio, and a sodium/creatinine ratio. The determination control unit compares the spot urine nutritional component index with a reference value preset for the spot urine nutritional component index for each of spot urine nutritional component indexes, and determines whether or not the spot urine nutritional component index is equal to or more than the reference value. The decision control unit decides a diet evaluation pattern indicating a balance of the diet of the human from the determination result for each of the determined spot urine nutritional component indexes. The output control unit outputs a diet evaluation comment improving the balance of the diet of the human.

Abstract: The present invention provides a composition for preventing or treating diseases accompanied by a decrease in bone weight, hypertension and diseases resulting from hypertension, the composition containing, as an active component, at least one member selected from the a compound represented by formula (I) wherein A and B are the same or different and are independently selected from the group consisting of halogen, amino, amidino, anilinoamide, mercapto, sulfonic acid, phosphate, carboxy, hydroxy C1–C5 alkyl, sugar residue, —OR1, and —OCOR2; wherein R1 is selected from the group consisting of hydrogen, C1–C5 alkyl, hydroxy C1–C5 alkyl, and C2–C5 alkenyl; and R2 is selected from the group consisting of C1–C5 alkyl, hydroxy C1–C5 alkyl, and C2–C5 alkenyl; n is number of substituents A present and is a number from 0 to 5; and m is number of substituents B present and is a number from 0 to 5.

Abstract: A preventive for circulatory diseases which can prevent the onset of circulatory diseases, particularly cerebral stroke, without causing adverse effects such as blood-pressure fluctuation. The preventive contains as the active ingredient a low-molecular-weight peptide fraction prepared by the trypsinization of casein followed by partial purification.